Original Research
Accepted on 01 Jul 2025
Cost-Effectiveness Analysis of Belzutifan for Advanced Renal Cell Carcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1556394
Type at least 3 characters
1,935 articles
Original Research
Published on 01 Jul 2025
Mapping the knowledge network of extracellular vesicles and angiogenesis in tumor-immune communication: a scientometric analysis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1568365
- 236 views
Mini Review
Accepted on 30 Jun 2025
Exploring MicroRNA Targeting as a Promising Approach for Solid Tumor Treatment
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1570093
Original Research
Accepted on 30 Jun 2025
Genomic instability and CCNE1 amplification as emerging biomarkers for stratifying High-Grade Serous Ovarian Cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1633410
Review
Accepted on 30 Jun 2025
Polyploid Giant Cancer Cells and Tumor Budding: Translation from Basic Research to Clinical Application
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1611920
Original Research
Published on 30 Jun 2025
PALB2 deficiency may sensitize H3K27M-mutant pediatric HGG cells to BMN673/talazoparib
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1589396
- 365 views
Original Research
Published on 30 Jun 2025
Efficacy and safety of cadonilimab (PD-1/CTLA-4 bi-specific antibody) and adjuvant anti-angiogenesis therapy in treated, recurrent, or metastatic cervical cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1614434
- 324 views
Review
Published on 27 Jun 2025
Advances of HDAC inhibitors in tumor therapy: potential applications through immune modulation
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1576781
- 305 views
Original Research
Accepted on 26 Jun 2025
Elevated Plasma Levels of WAP Four-Disulfide Core Domain 2 as a Potential Prognostic Biomarker for Various Cancers
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1614102
- 212 views
Editorial
Accepted on 26 Jun 2025
Editorial: "Advancements in Drug Development: Exploring Bi-Specific Antibodies as Promising Therapeutic Strategies in Oncology"
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1651944
- 143 views
Technology and Code
Accepted on 26 Jun 2025
A structure-based tool to interpret the significance of kinase mutations in clinical next generation sequencing in cancer
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1599389
Original Research
Published on 25 Jun 2025
Multidimensional analysis suggests that ZNF433 is a promising biomarker for the diagnosis and prognosis of human cancers
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1584042
- 445 views
Original Research
Published on 25 Jun 2025
Exploration of the role and mechanism of Rhizoma Paridis total saponins in osteosarcoma based on SPI1/LCN2-mediated ferroptosis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1592862
- 299 views
Original Research
Accepted on 24 Jun 2025
Targeting PDCD4 in Cancer and Atrial Fibrillation: Mechanistic Insights from Integrated Multi-Omics and Single-Cell Analysis
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1593815
- 105 views
Original Research
Accepted on 24 Jun 2025
Identification of novel molecular subtypes and construction of a prognostic signature via multi-omics analysis and machine learning in lung adenocarcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1590216
- 140 views
Original Research
Published on 24 Jun 2025
Network pharmacology integrated with molecular docking and experimental validation elucidates the therapeutic potential of Forsythiae Fructus extract against hepatitis B virus-related hepatocellular carcinoma
in Cancer Molecular Targets and Therapeutics
Frontiers in Oncology
doi 10.3389/fonc.2025.1571537
- 348 views